Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

July 8, 2021

Alcohol-Cancer Link Needs More Recognition

Author(s):

Brielle Benyon

Most people surveyed knew about the link between alcohol and liver cancer, but far fewer knew that drinking could increase breast cancer risk, too.

Alcohol consumption can be linked to multiple types of cancer, and the American Cancer Society even recommended last year that individuals should stop drinking alcohol to decrease their cancer risk.

While thousands of cancer-related deaths can be tied to alcohol each year, a small study published in BMC Public Health found that there is a need for better public education on what kinds of cancers can be caused by drinking.

“In general, awareness of the risk of alcohol for certain types of cancer was low to moderate, reflecting a need to inform people not only that alcohol increases risk of cancer, but which types of cancer are most highly associated (with) alcohol,” the researchers wrote.

The researchers surveyed 1,759 individuals aged 21 or older at the 2019 Minnesota State Fair to understand their knowledge on the association of drinking with breast, liver and colorectal cancer. They looked at predictors of overall awareness of alcohol as a risk factor and prevalence of awareness of alcohol as a risk factor for each of the cancer types.

Most participants identified alcohol as a risk factor for cancer. However, the percentages varied by cancer type. Only 38% of people knew that breast cancer could be related to alcohol consumption, while 92% of people associated alcohol with liver cancer risk. Fifty-one percent of respondents were aware of the link between alcohol and laryngeal cancer, and 66% for colon/rectal and mouth/throat cancers.

About a third (32%) of the people surveyed said that they had a binge drinking session within the last 30 days. Binge drinking was associated with a higher probability of awareness of the correlation between alcohol and cancer overall, though a decreased awareness for mouth and throat cancers.

Twelve percent said that they were diagnosed with cancer at some point in their life, and 79% said that they knew a family member who has been diagnosed. A total of 66% of participants had a bachelor’s degree or higher, which the researchers said might be a factor in why such a high percentage reported knowing about the alcohol-cancer connection.

“In our sample, 87% of participants correctly identified alcohol consumption as a risk factor for cancer,” the researchers wrote. “These findings (are) inconsistent with prior studies, which have shown low awareness of this risk (under 50%).”

But prior studies also found that people most strongly associate alcohol with liver cancer risk.

“High awareness of the connection between alcohol and liver cancer may relate to awareness that alcohol causes liver problems, such as cirrhosis of the liver,” the researchers said. “In addition, people may surmise that alcohol can cause damage to the mouth and throat given their direct contact with alcohol when consuming. Awareness for breast cancer may also be low because of this and other factors.”

The researchers also noted that when alcohol companies advertise their drinks using breast cancer awareness imagery – something that is particularly prevalent in October, which is Breast Cancer Awareness Month – it may “undermine efforts to raise awareness about the link between alcohol and breast cancer.”

While there was high awareness of alcohol’s impact on liver cancer risk, efforts must be made on the impact it can have on other cancers, according to the researchers. This can be done by way of organizations and nonprofits discouraging alcohol sponsorships, screening for alcohol use during health care visits, and implementing policies that can generate support for reduced alcohol consumption.

“(A)wareness for certain types of cancer was low to moderate, reflecting a need to inform people not only that alcohol increases risk of cancer, but which types of cancer alcohol increases the risk of,” the researchers said.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Speaking Out
Related Content
Advertisement
FDA text.
July 7th 2025

FDA Approves SIR-Spheres for Liver Cancer Treatment

Spencer Feldman
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both HCC and mCRC.
Marshall Morris, the founder of Dying Defiantly
December 8th 2022

Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story

Sailaja Darisipudi Andy Polhamus
After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.
FDA Approval
April 11th 2025

FDA Approves Opdivo Plus Yervoy for Advanced HCC

Alex Biese
The FDA has approved Opdivo with Yervoy for the first-line treatment of adults with unresectable or metastatic hepatocellular carcinoma.
Making Art From Cancer
December 10th 2020

Making Art From Cancer

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with renowned street artist James Cochran about one of his art projects that was commissioned to symbolize the creativity and commitment of those who work tirelessly to eradicate cancer.
Illusration of liver.
February 19th 2025

SBRT May Be Superior to Radiofrequency Ablation in Liver Cancer

Spencer Feldman
SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
Illustration of the liver.
January 25th 2025

Opdivo Plus Yervoy May Improve Survival and Responses in Frontline uHCC

Jordyn Sava
Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in the CheckMate 9DW study.
Related Content
Advertisement
FDA text.
July 7th 2025

FDA Approves SIR-Spheres for Liver Cancer Treatment

Spencer Feldman
The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in the U.S. for both HCC and mCRC.
Marshall Morris, the founder of Dying Defiantly
December 8th 2022

Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story

Sailaja Darisipudi Andy Polhamus
After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.
FDA Approval
April 11th 2025

FDA Approves Opdivo Plus Yervoy for Advanced HCC

Alex Biese
The FDA has approved Opdivo with Yervoy for the first-line treatment of adults with unresectable or metastatic hepatocellular carcinoma.
Making Art From Cancer
December 10th 2020

Making Art From Cancer

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with renowned street artist James Cochran about one of his art projects that was commissioned to symbolize the creativity and commitment of those who work tirelessly to eradicate cancer.
Illusration of liver.
February 19th 2025

SBRT May Be Superior to Radiofrequency Ablation in Liver Cancer

Spencer Feldman
SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.
Illustration of the liver.
January 25th 2025

Opdivo Plus Yervoy May Improve Survival and Responses in Frontline uHCC

Jordyn Sava
Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in the CheckMate 9DW study.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.